Wells Fargo’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$994K Sell
46,466
-73,697
-61% -$1.53M ﹤0.01% 3738
2025
Q4
$2.57M Buy
120,163
+41,108
+52% +$842K ﹤0.01% 3240
2025
Q3
$1.32M Buy
79,055
+9,985
+14% +$150K ﹤0.01% 3608
2025
Q2
$991K Buy
69,070
+2,498
+4% +$34.3K ﹤0.01% 3692
2025
Q1
$965K Buy
66,572
+544
+0.8% +$7.73K ﹤0.01% 3669
2024
Q4
$866K Buy
66,028
+6,521
+11% +$90K ﹤0.01% 3806
2024
Q3
$690K Buy
59,507
+673
+1% +$6.35K ﹤0.01% 3789
2024
Q2
$444K Sell
58,834
-157,034
-73% -$1.3M ﹤0.01% 3990
2024
Q1
$2.17M Buy
215,868
+30,366
+16% +$283K ﹤0.01% 2911
2023
Q4
$1.73M Sell
185,502
-43,300
-19% -$448K ﹤0.01% 3024
2023
Q3
$2.91M Sell
228,802
-22,492
-9% -$309K ﹤0.01% 2504
2023
Q2
$3.57M Buy
251,294
+714
+0.3% +$10K ﹤0.01% 2422
2023
Q1
$3.74M Buy
250,580
+29,662
+13% +$449K ﹤0.01% 2346
2022
Q4
$3.28M Sell
220,918
-32,661
-13% -$533K ﹤0.01% 2385
2022
Q3
$4.19M Buy
253,579
+20,716
+9% +$417K ﹤0.01% 2134
2022
Q2
$4.89M Sell
232,863
-24,491
-10% -$500K ﹤0.01% 2120
2022
Q1
$6.04M Sell
257,354
-6,660
-3% -$163K ﹤0.01% 2280
2021
Q4
$7.18M Buy
264,014
+12,022
+5% +$322K ﹤0.01% 2185
2021
Q3
$7.17M Sell
251,992
-7,914
-3% -$241K ﹤0.01% 2512
2021
Q2
$7.84M Sell
259,906
-94,446
-27% -$2.79M ﹤0.01% 2438
2021
Q1
$9.03M Buy
354,352
+139,260
+65% +$3.57M ﹤0.01% 2290
2020
Q4
$5.28M Buy
215,092
+104,894
+95% +$1.97M ﹤0.01% 2695
2020
Q3
$1.79M Sell
110,198
-9,161
-8% -$170K ﹤0.01% 3405
2020
Q2
$2.04M Sell
119,359
-33,357
-22% -$495K ﹤0.01% 3248
2020
Q1
$1.78M Buy
152,716
+12,190
+9% +$251K ﹤0.01% 3105
2019
Q4
$3.9M Sell
140,526
-68,207
-33% -$1.71M ﹤0.01% 2787
2019
Q3
$4.72M Sell
208,733
-184,781
-47% -$4.21M ﹤0.01% 2596
2019
Q2
$9.93M Buy
393,514
+14,973
+4% +$402K ﹤0.01% 1968
2019
Q1
$10.3M Buy
378,541
+9,064
+2% +$304K ﹤0.01% 1924
2018
Q4
$12.2M Sell
369,477
-38,255
-9% -$1.54M ﹤0.01% 1719
2018
Q3
$19M Sell
407,732
-479,223
-54% -$22M 0.01% 1534
2018
Q2
$38.4M Buy
886,955
+43,426
+5% +$2.08M 0.01% 1061
2018
Q1
$46.9M Buy
843,529
+4,647
+0.6% +$255K 0.01% 937
2017
Q4
$44.8M Buy
838,882
+359,288
+75% +$17M 0.01% 949
2017
Q3
$20.7M Buy
479,594
+4,470
+0.9% +$212K 0.01% 1405
2017
Q2
$28.7M Sell
475,124
-173,332
-27% -$10.3M 0.01% 1166
2017
Q1
$45M Sell
648,456
-21,762
-3% -$1.51M 0.01% 902
2016
Q4
$44.7M Buy
670,218
+18,176
+3% +$1.18M 0.02% 891
2016
Q3
$43.2M Buy
652,042
+19,791
+3% +$1.35M 0.02% 851
2016
Q2
$45.8M Sell
632,251
-2,947
-0.5% -$203K 0.02% 798
2016
Q1
$41M Buy
635,198
+56,580
+10% +$3.75M 0.02% 861
2015
Q4
$41.5M Sell
578,618
-12,961
-2% -$959K 0.02% 856
2015
Q3
$45.4M Sell
591,579
-66,542
-10% -$5.37M 0.02% 795
2015
Q2
$48.8M Buy
658,121
+8,464
+1% +$609K 0.02% 824
2015
Q1
$47.1M Sell
649,657
-23,071
-3% -$1.6M 0.02% 832
2014
Q4
$44.5M Sell
672,728
-1,179,809
-64% -$72M 0.02% 813
2014
Q3
$102M Sell
1,852,537
-60,202
-3% -$3.42M 0.04% 443
2014
Q2
$111M Buy
1,912,739
+1,199,712
+168% +$70.6M 0.05% 445
2014
Q1
$44.2M Sell
713,027
-48,465
-6% -$2.82M 0.02% 817
2013
Q4
$40.6M Sell
761,492
-98,422
-11% -$5.28M 0.02% 854
2013
Q3
$43.2M Sell
859,914
-602
-0.1% -$29.4K 0.02% 757
2013
Q2
$39.4M Buy
+860,516
New +$38.5M 0.02% 745

Other funds holding MD

Wells Fargo's MD Position: Q1 2026 in Review

Wells Fargo reduced its Pediatrix Medical (MD) stake by 61% in Q1 2026, selling an estimated $1.53M and leaving 46,466 shares worth $994K. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

Wells Fargo first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $111M in Q2 2014. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Wells Fargo held 46,466 shares of Pediatrix Medical worth $994K as of Q1 2026.
  • Wells Fargo sold 73,697 Pediatrix Medical shares in Q1 2026, an estimated $1.53M.
  • Pediatrix Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3738 holding.
  • Wells Fargo first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Pediatrix Medical position peaked at $111M in Q2 2014.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.